View ValuationCentre Testing International Group 향후 성장Future 기준 점검 1/6Centre Testing International Group (는) 각각 연간 14.4% 및 12.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 14.2% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 14.6% 로 예상됩니다.핵심 정보14.4%이익 성장률14.24%EPS 성장률Professional Services 이익 성장21.0%매출 성장률12.2%향후 자기자본이익률14.60%애널리스트 커버리지Good마지막 업데이트03 Aug 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesBuy Or Sell Opportunity • Jul 14Now 20% overvaluedOver the last 90 days, the stock has fallen 13% to CN¥13.31. The fair value is estimated to be CN¥11.09, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Earnings per share has grown by 2.7%. Revenue is forecast to grow by 29% in 2 years. Earnings are forecast to grow by 34% in the next 2 years.공고 • Jun 30Centre Testing International Group Co. Ltd. to Report First Half, 2026 Results on Aug 17, 2026Centre Testing International Group Co. Ltd. announced that they will report first half, 2026 results on Aug 17, 2026공고 • Mar 31+ 1 more updateCentre Testing International Group Co. Ltd. to Report Q1, 2026 Results on Apr 20, 2026Centre Testing International Group Co. Ltd. announced that they will report Q1, 2026 results on Apr 20, 2026공고 • Dec 31Centre Testing International Group Co. Ltd. to Report Fiscal Year 2025 Results on Mar 31, 2026Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2025 results on Mar 31, 2026공고 • Oct 17Centre Testing International Group Co. Ltd. (SZSE:300012) acquired Laboratoire Midac.Centre Testing International Group Co. Ltd. (SZSE:300012) acquired Laboratoire Midac on October 15, 2025. MBA Capital acted as financial advisor for Laboratoire Midac. Centre Testing International Group Co. Ltd. (SZSE:300012) completed the acquisition of Laboratoire Midac on October 15, 2025.공고 • Sep 30Centre Testing International Group Co. Ltd. to Report Q3, 2025 Results on Oct 27, 2025Centre Testing International Group Co. Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025공고 • Jul 02Centre Testing International Group Co. Ltd. to Report First Half, 2025 Results on Aug 22, 2025Centre Testing International Group Co. Ltd. announced that they will report first half, 2025 results on Aug 22, 2025공고 • May 22Centre Testing International Group Co. Ltd. Announces Final Cash Dividend Plan on A Shares for 2024, Payable on 28 May 2025Centre Testing International Group Co. Ltd. announced final profit distribution plan on A shares: Cash dividend/10 shares (tax included) of CNY 1.00000000 for the year 2024. Record date is 27 May 2025. Ex-date is 28 May 2025. Payment date is 28 May 2025.공고 • Apr 18Centre Testing International Group Co. Ltd., Annual General Meeting, May 19, 2025Centre Testing International Group Co. Ltd., Annual General Meeting, May 19, 2025, at 14:30 China Standard Time. Location: No. 4, Liuxian 3rd Road, Xin'an Subdistrict, Bao'an District, Shenzhen, Guangdong China공고 • Mar 31Centre Testing International Group Co. Ltd. to Report Q1, 2025 Results on Apr 18, 2025Centre Testing International Group Co. Ltd. announced that they will report Q1, 2025 results on Apr 18, 2025공고 • Dec 31Centre Testing International Group Co. Ltd. to Report Fiscal Year 2024 Results on Apr 18, 2025Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2024 results on Apr 18, 2025Buy Or Sell Opportunity • Nov 05Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 24% to CN¥14.65. The fair value is estimated to be CN¥11.80, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 8.1%. Revenue is forecast to grow by 27% in 2 years. Earnings are forecast to grow by 35% in the next 2 years.Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.19 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.19 (in line with 3Q 2023). Revenue: CN¥1.61b (up 5.7% from 3Q 2023). Net income: CN¥310.1m (flat on 3Q 2023). Profit margin: 19% (down from 21% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.Buy Or Sell Opportunity • Oct 18Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 33% to CN¥14.75. The fair value is estimated to be CN¥12.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 10%. Revenue is forecast to grow by 31% in 2 years. Earnings are forecast to grow by 37% in the next 2 years.New Risk • Sep 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Buy Or Sell Opportunity • Sep 30Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 58% to CN¥15.04. The fair value is estimated to be CN¥12.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 10%. Revenue is forecast to grow by 31% in 2 years. Earnings are forecast to grow by 36% in the next 2 years.공고 • Sep 30Centre Testing International Group Co. Ltd. to Report Q3, 2024 Results on Oct 25, 2024Centre Testing International Group Co. Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 24%After last week's 24% share price gain to CN¥13.06, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 17x in the Professional Services industry in China. Total loss to shareholders of 48% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.07 per share.Reported Earnings • Aug 12Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.17 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.17 in 2Q 2023). Revenue: CN¥1.60b (up 11% from 2Q 2023). Net income: CN¥304.1m (up 7.1% from 2Q 2023). Profit margin: 19% (in line with 2Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.Board Change • Aug 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Guancheng Qi was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • Jul 09Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥11.27, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 14x in the Professional Services industry in China. Total loss to shareholders of 63% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.77 per share.공고 • Jul 05Centre Testing International Group Co. Ltd. (SZSE:300012) announces an Equity Buyback for 3,000,000 shares, for CNY 50.49 million.Centre Testing International Group Co. Ltd. (SZSE:300012) announces a share repurchase program. Under the program, the company will repurchase up to 3,000,000 shares for a total purchase price of not more than CNY 50.49 million. The shares will be repurchased at a price not more than CNY 16.83 per share. The program will be funded using the company's own funds. The repurchased shares will be used for employee stock ownership plans or equity incentives. The program will be valid for a period of 12 months.공고 • Jun 29Centre Testing International Group Co. Ltd. to Report First Half, 2024 Results on Aug 12, 2024Centre Testing International Group Co. Ltd. announced that they will report first half, 2024 results on Aug 12, 2024Declared Dividend • May 20Dividend of CN¥0.10 announcedShareholders will receive a dividend of CN¥0.10. Ex-date: 24th May 2024 Payment date: 24th May 2024 Dividend yield will be 0.8%, which is lower than the industry average of 1.5%. Sustainability & Growth Dividend is well covered by both earnings (19% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 51% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Buy Or Sell Opportunity • Apr 29Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to CN¥12.95. The fair value is estimated to be CN¥10.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 37% in the next 2 years.Reported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.079 (vs CN¥0.086 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.079 (down from CN¥0.086 in 1Q 2023). Revenue: CN¥1.19b (up 6.7% from 1Q 2023). Net income: CN¥132.5m (down 8.1% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.공고 • Apr 20Centre Testing International Group Co. Ltd., Annual General Meeting, May 10, 2024Centre Testing International Group Co. Ltd., Annual General Meeting, May 10, 2024, at 14:30 China Standard Time. Location: No. 4, Liuxian 3rd Road, Xin'an Subdistrict, Bao'an District, Shenzhen, Guangdong ChinaBuy Or Sell Opportunity • Apr 12Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to CN¥11.54. The fair value is estimated to be CN¥14.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 13% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.공고 • Mar 30Centre Testing International Group Co. Ltd. to Report Q1, 2024 Results on Apr 19, 2024Centre Testing International Group Co. Ltd. announced that they will report Q1, 2024 results on Apr 19, 2024Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥13.39, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 14x in the Professional Services industry in China. Total loss to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.30 per share.Buy Or Sell Opportunity • Jan 25Now 21% overvaluedOver the last 90 days, the stock has fallen 11% to CN¥13.45. The fair value is estimated to be CN¥11.09, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 14% per annum over the same time period.Valuation Update With 7 Day Price Move • Jan 18Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥11.35, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Professional Services industry in China. Total loss to shareholders of 59% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥17.57 per share.공고 • Dec 29Centre Testing International Group Co. Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2023 results on Apr 23, 2024Buying Opportunity • Dec 25Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 25%. The fair value is estimated to be CN¥17.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings is also forecast to grow by 18% per annum over the same time period.Reported Earnings • Oct 25Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.19 (up from CN¥0.18 in 3Q 2022). Revenue: CN¥1.53b (up 5.7% from 3Q 2022). Net income: CN¥312.7m (up 3.4% from 3Q 2022). Profit margin: 21% (in line with 3Q 2022). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.14 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.17 (up from CN¥0.14 in 2Q 2022). Revenue: CN¥1.44b (up 14% from 2Q 2022). Net income: CN¥283.9m (up 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.공고 • Jul 01Centre Testing International Group Co. Ltd. to Report First Half, 2023 Results on Aug 18, 2023Centre Testing International Group Co. Ltd. announced that they will report first half, 2023 results on Aug 18, 2023공고 • May 19+ 1 more updateCentre Testing International Group Co. Ltd. Implements Final Profit Distribution Plan of A Share for 2022, Payable on 25 May 2023Centre Testing International Group Co. Ltd. announced 2022 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 0.60000000. Record date: 24 May 2023, Ex-date: 25 May 2023, Payment date: 25 May 2023.공고 • May 17Centre Testing International Group Co. Ltd. (SZSE:300012) announces an Equity Buyback for CNY 125 million worth of its shares.Centre Testing International Group Co. Ltd. (SZSE:300012) announces a share repurchase program. Under the program, the company will repurchase up to CNY 125 million worth of its shares. The program will be valid for a period of 12 months.Reported Earnings • Apr 26First quarter 2023 earnings released: EPS: CN¥0.086 (vs CN¥0.071 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.086 (up from CN¥0.071 in 1Q 2022). Revenue: CN¥1.12b (up 23% from 1Q 2022). Net income: CN¥144.3m (up 20% from 1Q 2022). Profit margin: 13% (in line with 1Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 01Full year 2022 earnings released: EPS: CN¥0.54 (vs CN¥0.45 in FY 2021)Full year 2022 results: EPS: CN¥0.54 (up from CN¥0.45 in FY 2021). Revenue: CN¥5.13b (up 19% from FY 2021). Net income: CN¥902.3m (up 21% from FY 2021). Profit margin: 18% (in line with FY 2021). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.공고 • Jan 04Centre Testing International Group Co. Ltd. Announces Management ElectionsCentre Testing International Group Co. Ltd. at its EGM held on December 30, 2022 approved election of Liu Jidi as non-independent directors, Cheng Haijin, Zeng Fanli and Liu Zhiquan as independent directors and Du Xuezhi as non-employee supervisors.Board Change • Jan 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. Supervisor Jin Ou was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.15 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.18 (up from CN¥0.15 in 3Q 2021). Revenue: CN¥1.44b (up 20% from 3Q 2021). Net income: CN¥302.3m (up 20% from 3Q 2021). Profit margin: 21% (in line with 3Q 2021). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.12 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2021). Revenue: CN¥1.26b (up 21% from 2Q 2021). Net income: CN¥241.1m (up 20% from 2Q 2021). Profit margin: 19% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 23%, compared to a 33% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 19% per year.Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.071 (vs CN¥0.06 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.071 (up from CN¥0.06 in 1Q 2021). Revenue: CN¥907.7m (up 19% from 1Q 2021). Net income: CN¥119.8m (up 20% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 24%, compared to a 29% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 29% per year.Reported Earnings • Feb 28Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: CN¥0.45 (up from CN¥0.35 in FY 2020). Revenue: CN¥4.33b (up 21% from FY 2020). Net income: CN¥745.7m (up 29% from FY 2020). Profit margin: 17% (in line with FY 2020). Revenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 22%, compared to a 31% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.12 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.20b (up 19% from 3Q 2020). Net income: CN¥252.4m (up 23% from 3Q 2020). Profit margin: 21% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 62% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 27Second quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.11 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥1.05b (up 19% from 2Q 2020). Net income: CN¥201.2m (up 12% from 2Q 2020). Profit margin: 19% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 04Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥29.25, the stock trades at a forward P/E ratio of 60x. Average forward P/E is 34x in the Professional Services industry in China. Total returns to shareholders of 419% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.75 per share.Reported Earnings • Apr 21Full year 2020 earnings released: EPS CN¥0.35 (vs CN¥0.29 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.57b (up 12% from FY 2019). Net income: CN¥577.6m (up 21% from FY 2019). Profit margin: 16% (up from 15% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 86% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥24.43, the stock is trading at a trailing P/E ratio of 78.9x, down from the previous P/E ratio of 95.8x. This compares to an average P/E of 29x in the Professional Services industry in China. Total returns to shareholders over the past three years are 495%.Is New 90 Day High Low • Jan 22New 90-day high: CN¥31.35The company is up 22% from its price of CN¥25.61 on 23 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is down 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥7.27 per share.Is New 90 Day High Low • Jan 05New 90-day high: CN¥27.83The company is up 14% from its price of CN¥24.43 on 30 September 2020. The Chinese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥8.62 per share.Is New 90 Day High Low • Nov 03New 90-day high: CN¥27.64The company is up 6.0% from its price of CN¥25.96 on 05 August 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥7.43 per share.Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥514.4m, up 9.7% from the prior year. Total revenue was CN¥3.33b over the last 12 months, up 9.0% from the prior year.Analyst Estimate Surprise Post Earnings • Oct 28Third-quarter earnings released: Revenue misses expectationsThird-quarter revenue missed analyst estimates by 3.6% at CN¥1.01b. Revenue is forecast to grow 27% over the next year, compared to a 33% growth forecast for the Professional Services industry in China.이익 및 매출 성장 예측XSEC:300012 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20289,5861,5738471,8461012/31/20278,5211,3757711,6191312/31/20267,5701,1749621,515133/31/20266,8291,0597361,463N/A12/31/20256,6211,0167131,371N/A9/30/20256,3909877091,385N/A6/30/20256,2539525011,215N/A3/31/20256,1799254081,143N/A12/31/20246,0849213721,063N/A9/30/20245,919916342991N/A6/30/20245,846919361977N/A3/31/20245,679898371977N/A12/31/20235,6059104691,122N/A9/30/20235,5979803641,054N/A6/30/20235,5099704651,159N/A3/31/20235,3409275051,174N/A1/1/20235,1319034581,100N/A9/30/20224,9338564541,080N/A6/30/20224,6928063971,000N/A3/31/20224,475766388997N/A1/1/20224,3297465121,073N/A9/30/20214,2307334461,000N/A6/30/20214,0376873871,033N/A3/31/20213,8736644521,066N/A12/31/20203,568578385931N/A9/30/20203,328514379888N/A6/30/20203,191509355760N/A3/31/20203,074444234665N/A1/1/20203,183476N/A795N/A9/30/20193,051469N/A699N/A6/30/20192,923379N/A785N/A3/31/20192,798340N/A708N/A12/31/20182,681270N/A684N/A9/30/20182,538195N/A477N/A6/30/20182,358145N/A293N/A3/31/20182,191106N/A322N/A12/31/20172,118134N/A349N/A9/30/20171,998127N/A413N/A6/30/20171,866125N/A431N/A3/31/20171,768113N/A390N/A12/31/20161,652102N/A363N/A9/30/20161,506181N/A281N/A6/30/20161,391158N/A250N/A3/31/20161,312170N/A228N/A12/31/20151,288181N/A277N/A9/30/20151,155137N/A241N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 300012 의 연간 예상 수익 증가율(14.4%)이 saving rate(2.4%)보다 높습니다.수익 vs 시장: 300012 의 연간 수익(14.4%)이 CN 시장(26.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 300012 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 300012 의 수익(연간 12.2%)이 CN 시장(연간 16.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 300012 의 수익(연간 12.2%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 300012의 자본 수익률은 3년 후 14.6%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YCommercial-services 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/13 22:04종가2026/08/13 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Centre Testing International Group Co. Ltd.는 28명의 분석가가 다루고 있습니다. 이 중 13명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yikai LiuBofA Global ResearchPei LuChina Galaxy Securities Co., Ltd.Jia YanChina International Capital Corporation Limited25명의 분석가 더 보기
Buy Or Sell Opportunity • Jul 14Now 20% overvaluedOver the last 90 days, the stock has fallen 13% to CN¥13.31. The fair value is estimated to be CN¥11.09, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years. Earnings per share has grown by 2.7%. Revenue is forecast to grow by 29% in 2 years. Earnings are forecast to grow by 34% in the next 2 years.
공고 • Jun 30Centre Testing International Group Co. Ltd. to Report First Half, 2026 Results on Aug 17, 2026Centre Testing International Group Co. Ltd. announced that they will report first half, 2026 results on Aug 17, 2026
공고 • Mar 31+ 1 more updateCentre Testing International Group Co. Ltd. to Report Q1, 2026 Results on Apr 20, 2026Centre Testing International Group Co. Ltd. announced that they will report Q1, 2026 results on Apr 20, 2026
공고 • Dec 31Centre Testing International Group Co. Ltd. to Report Fiscal Year 2025 Results on Mar 31, 2026Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2025 results on Mar 31, 2026
공고 • Oct 17Centre Testing International Group Co. Ltd. (SZSE:300012) acquired Laboratoire Midac.Centre Testing International Group Co. Ltd. (SZSE:300012) acquired Laboratoire Midac on October 15, 2025. MBA Capital acted as financial advisor for Laboratoire Midac. Centre Testing International Group Co. Ltd. (SZSE:300012) completed the acquisition of Laboratoire Midac on October 15, 2025.
공고 • Sep 30Centre Testing International Group Co. Ltd. to Report Q3, 2025 Results on Oct 27, 2025Centre Testing International Group Co. Ltd. announced that they will report Q3, 2025 results on Oct 27, 2025
공고 • Jul 02Centre Testing International Group Co. Ltd. to Report First Half, 2025 Results on Aug 22, 2025Centre Testing International Group Co. Ltd. announced that they will report first half, 2025 results on Aug 22, 2025
공고 • May 22Centre Testing International Group Co. Ltd. Announces Final Cash Dividend Plan on A Shares for 2024, Payable on 28 May 2025Centre Testing International Group Co. Ltd. announced final profit distribution plan on A shares: Cash dividend/10 shares (tax included) of CNY 1.00000000 for the year 2024. Record date is 27 May 2025. Ex-date is 28 May 2025. Payment date is 28 May 2025.
공고 • Apr 18Centre Testing International Group Co. Ltd., Annual General Meeting, May 19, 2025Centre Testing International Group Co. Ltd., Annual General Meeting, May 19, 2025, at 14:30 China Standard Time. Location: No. 4, Liuxian 3rd Road, Xin'an Subdistrict, Bao'an District, Shenzhen, Guangdong China
공고 • Mar 31Centre Testing International Group Co. Ltd. to Report Q1, 2025 Results on Apr 18, 2025Centre Testing International Group Co. Ltd. announced that they will report Q1, 2025 results on Apr 18, 2025
공고 • Dec 31Centre Testing International Group Co. Ltd. to Report Fiscal Year 2024 Results on Apr 18, 2025Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2024 results on Apr 18, 2025
Buy Or Sell Opportunity • Nov 05Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 24% to CN¥14.65. The fair value is estimated to be CN¥11.80, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 8.1%. Revenue is forecast to grow by 27% in 2 years. Earnings are forecast to grow by 35% in the next 2 years.
Reported Earnings • Oct 25Third quarter 2024 earnings released: EPS: CN¥0.19 (vs CN¥0.19 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.19 (in line with 3Q 2023). Revenue: CN¥1.61b (up 5.7% from 3Q 2023). Net income: CN¥310.1m (flat on 3Q 2023). Profit margin: 19% (down from 21% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 20% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
Buy Or Sell Opportunity • Oct 18Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 33% to CN¥14.75. The fair value is estimated to be CN¥12.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 10%. Revenue is forecast to grow by 31% in 2 years. Earnings are forecast to grow by 37% in the next 2 years.
New Risk • Sep 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Buy Or Sell Opportunity • Sep 30Now 24% overvalued after recent price riseOver the last 90 days, the stock has risen 58% to CN¥15.04. The fair value is estimated to be CN¥12.08, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 12% over the last 3 years. Earnings per share has grown by 10%. Revenue is forecast to grow by 31% in 2 years. Earnings are forecast to grow by 36% in the next 2 years.
공고 • Sep 30Centre Testing International Group Co. Ltd. to Report Q3, 2024 Results on Oct 25, 2024Centre Testing International Group Co. Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment improves as stock rises 24%After last week's 24% share price gain to CN¥13.06, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 17x in the Professional Services industry in China. Total loss to shareholders of 48% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.07 per share.
Reported Earnings • Aug 12Second quarter 2024 earnings released: EPS: CN¥0.18 (vs CN¥0.17 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.18 (up from CN¥0.17 in 2Q 2023). Revenue: CN¥1.60b (up 11% from 2Q 2023). Net income: CN¥304.1m (up 7.1% from 2Q 2023). Profit margin: 19% (in line with 2Q 2023). Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
Board Change • Aug 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Director Guancheng Qi was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • Jul 09Investor sentiment improves as stock rises 18%After last week's 18% share price gain to CN¥11.27, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 14x in the Professional Services industry in China. Total loss to shareholders of 63% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥10.77 per share.
공고 • Jul 05Centre Testing International Group Co. Ltd. (SZSE:300012) announces an Equity Buyback for 3,000,000 shares, for CNY 50.49 million.Centre Testing International Group Co. Ltd. (SZSE:300012) announces a share repurchase program. Under the program, the company will repurchase up to 3,000,000 shares for a total purchase price of not more than CNY 50.49 million. The shares will be repurchased at a price not more than CNY 16.83 per share. The program will be funded using the company's own funds. The repurchased shares will be used for employee stock ownership plans or equity incentives. The program will be valid for a period of 12 months.
공고 • Jun 29Centre Testing International Group Co. Ltd. to Report First Half, 2024 Results on Aug 12, 2024Centre Testing International Group Co. Ltd. announced that they will report first half, 2024 results on Aug 12, 2024
Declared Dividend • May 20Dividend of CN¥0.10 announcedShareholders will receive a dividend of CN¥0.10. Ex-date: 24th May 2024 Payment date: 24th May 2024 Dividend yield will be 0.8%, which is lower than the industry average of 1.5%. Sustainability & Growth Dividend is well covered by both earnings (19% earnings payout ratio) and cash flows (45% cash payout ratio). The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 51% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Buy Or Sell Opportunity • Apr 29Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 10% to CN¥12.95. The fair value is estimated to be CN¥10.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Earnings per share has grown by 12%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 37% in the next 2 years.
Reported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.079 (vs CN¥0.086 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.079 (down from CN¥0.086 in 1Q 2023). Revenue: CN¥1.19b (up 6.7% from 1Q 2023). Net income: CN¥132.5m (down 8.1% from 1Q 2023). Profit margin: 11% (down from 13% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
공고 • Apr 20Centre Testing International Group Co. Ltd., Annual General Meeting, May 10, 2024Centre Testing International Group Co. Ltd., Annual General Meeting, May 10, 2024, at 14:30 China Standard Time. Location: No. 4, Liuxian 3rd Road, Xin'an Subdistrict, Bao'an District, Shenzhen, Guangdong China
Buy Or Sell Opportunity • Apr 12Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to CN¥11.54. The fair value is estimated to be CN¥14.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 13% per annum. Earnings are also forecast to grow by 12% per annum over the same time period.
공고 • Mar 30Centre Testing International Group Co. Ltd. to Report Q1, 2024 Results on Apr 19, 2024Centre Testing International Group Co. Ltd. announced that they will report Q1, 2024 results on Apr 19, 2024
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improves as stock rises 21%After last week's 21% share price gain to CN¥13.39, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 14x in the Professional Services industry in China. Total loss to shareholders of 56% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.30 per share.
Buy Or Sell Opportunity • Jan 25Now 21% overvaluedOver the last 90 days, the stock has fallen 11% to CN¥13.45. The fair value is estimated to be CN¥11.09, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 14% per annum. Earnings are also forecast to grow by 14% per annum over the same time period.
Valuation Update With 7 Day Price Move • Jan 18Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥11.35, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Professional Services industry in China. Total loss to shareholders of 59% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥17.57 per share.
공고 • Dec 29Centre Testing International Group Co. Ltd. to Report Fiscal Year 2023 Results on Apr 23, 2024Centre Testing International Group Co. Ltd. announced that they will report fiscal year 2023 results on Apr 23, 2024
Buying Opportunity • Dec 25Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 25%. The fair value is estimated to be CN¥17.42, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 19%. For the next 3 years, revenue is forecast to grow by 16% per annum. Earnings is also forecast to grow by 18% per annum over the same time period.
Reported Earnings • Oct 25Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.18 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.19 (up from CN¥0.18 in 3Q 2022). Revenue: CN¥1.53b (up 5.7% from 3Q 2022). Net income: CN¥312.7m (up 3.4% from 3Q 2022). Profit margin: 21% (in line with 3Q 2022). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.14 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.17 (up from CN¥0.14 in 2Q 2022). Revenue: CN¥1.44b (up 14% from 2Q 2022). Net income: CN¥283.9m (up 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
공고 • Jul 01Centre Testing International Group Co. Ltd. to Report First Half, 2023 Results on Aug 18, 2023Centre Testing International Group Co. Ltd. announced that they will report first half, 2023 results on Aug 18, 2023
공고 • May 19+ 1 more updateCentre Testing International Group Co. Ltd. Implements Final Profit Distribution Plan of A Share for 2022, Payable on 25 May 2023Centre Testing International Group Co. Ltd. announced 2022 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 0.60000000. Record date: 24 May 2023, Ex-date: 25 May 2023, Payment date: 25 May 2023.
공고 • May 17Centre Testing International Group Co. Ltd. (SZSE:300012) announces an Equity Buyback for CNY 125 million worth of its shares.Centre Testing International Group Co. Ltd. (SZSE:300012) announces a share repurchase program. Under the program, the company will repurchase up to CNY 125 million worth of its shares. The program will be valid for a period of 12 months.
Reported Earnings • Apr 26First quarter 2023 earnings released: EPS: CN¥0.086 (vs CN¥0.071 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.086 (up from CN¥0.071 in 1Q 2022). Revenue: CN¥1.12b (up 23% from 1Q 2022). Net income: CN¥144.3m (up 20% from 1Q 2022). Profit margin: 13% (in line with 1Q 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 01Full year 2022 earnings released: EPS: CN¥0.54 (vs CN¥0.45 in FY 2021)Full year 2022 results: EPS: CN¥0.54 (up from CN¥0.45 in FY 2021). Revenue: CN¥5.13b (up 19% from FY 2021). Net income: CN¥902.3m (up 21% from FY 2021). Profit margin: 18% (in line with FY 2021). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 21% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
공고 • Jan 04Centre Testing International Group Co. Ltd. Announces Management ElectionsCentre Testing International Group Co. Ltd. at its EGM held on December 30, 2022 approved election of Liu Jidi as non-independent directors, Cheng Haijin, Zeng Fanli and Liu Zhiquan as independent directors and Du Xuezhi as non-employee supervisors.
Board Change • Jan 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. Supervisor Jin Ou was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Oct 27Third quarter 2022 earnings released: EPS: CN¥0.18 (vs CN¥0.15 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.18 (up from CN¥0.15 in 3Q 2021). Revenue: CN¥1.44b (up 20% from 3Q 2021). Net income: CN¥302.3m (up 20% from 3Q 2021). Profit margin: 21% (in line with 3Q 2021). Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 26Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.12 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2021). Revenue: CN¥1.26b (up 21% from 2Q 2021). Net income: CN¥241.1m (up 20% from 2Q 2021). Profit margin: 19% (in line with 2Q 2021). Over the next year, revenue is forecast to grow 23%, compared to a 33% growth forecast for the Professional Services industry in China. Over the last 3 years on average, earnings per share has increased by 23% per year whereas the company’s share price has increased by 19% per year.
Reported Earnings • Apr 27First quarter 2022 earnings released: EPS: CN¥0.071 (vs CN¥0.06 in 1Q 2021)First quarter 2022 results: EPS: CN¥0.071 (up from CN¥0.06 in 1Q 2021). Revenue: CN¥907.7m (up 19% from 1Q 2021). Net income: CN¥119.8m (up 20% from 1Q 2021). Profit margin: 13% (in line with 1Q 2021). Over the next year, revenue is forecast to grow 24%, compared to a 29% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 29% per year.
Reported Earnings • Feb 28Full year 2021 earnings: EPS in line with expectations, revenues disappointFull year 2021 results: EPS: CN¥0.45 (up from CN¥0.35 in FY 2020). Revenue: CN¥4.33b (up 21% from FY 2020). Net income: CN¥745.7m (up 29% from FY 2020). Profit margin: 17% (in line with FY 2020). Revenue missed analyst estimates by 1.4%. Over the next year, revenue is forecast to grow 22%, compared to a 31% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has increased by 34% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Oct 28Third quarter 2021 earnings released: EPS CN¥0.15 (vs CN¥0.12 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were flat. Third quarter 2021 results: Revenue: CN¥1.20b (up 19% from 3Q 2020). Net income: CN¥252.4m (up 23% from 3Q 2020). Profit margin: 21% (in line with 3Q 2020). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has increased by 62% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 27Second quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.11 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥1.05b (up 19% from 2Q 2020). Net income: CN¥201.2m (up 12% from 2Q 2020). Profit margin: 19% (down from 20% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has increased by 68% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 04Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥29.25, the stock trades at a forward P/E ratio of 60x. Average forward P/E is 34x in the Professional Services industry in China. Total returns to shareholders of 419% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.75 per share.
Reported Earnings • Apr 21Full year 2020 earnings released: EPS CN¥0.35 (vs CN¥0.29 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥3.57b (up 12% from FY 2019). Net income: CN¥577.6m (up 21% from FY 2019). Profit margin: 16% (up from 15% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has increased by 86% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Feb 27Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥24.43, the stock is trading at a trailing P/E ratio of 78.9x, down from the previous P/E ratio of 95.8x. This compares to an average P/E of 29x in the Professional Services industry in China. Total returns to shareholders over the past three years are 495%.
Is New 90 Day High Low • Jan 22New 90-day high: CN¥31.35The company is up 22% from its price of CN¥25.61 on 23 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is down 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥7.27 per share.
Is New 90 Day High Low • Jan 05New 90-day high: CN¥27.83The company is up 14% from its price of CN¥24.43 on 30 September 2020. The Chinese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥8.62 per share.
Is New 90 Day High Low • Nov 03New 90-day high: CN¥27.64The company is up 6.0% from its price of CN¥25.96 on 05 August 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Professional Services industry, which is flat over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥7.43 per share.
Reported Earnings • Oct 28Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥514.4m, up 9.7% from the prior year. Total revenue was CN¥3.33b over the last 12 months, up 9.0% from the prior year.
Analyst Estimate Surprise Post Earnings • Oct 28Third-quarter earnings released: Revenue misses expectationsThird-quarter revenue missed analyst estimates by 3.6% at CN¥1.01b. Revenue is forecast to grow 27% over the next year, compared to a 33% growth forecast for the Professional Services industry in China.